Gilead Sciences Inc.
Market Reports 📊 57 Reports
51. Significant Drug Launches in 2019: A BCC Research Analysis and Insights on Pharmaceutical Industry
This report provides information on the top potential drug launches by pharma companies in 2019. Knowledge about drug, mechanism of action, and briefing of clinical evidences
52. Global DNA Read, Write and Edit Market
The global market for DNA read, write and edit applications should grow from $17.0 billion in 2019 to $43.1 billion by 2024 with a compound annual growth rate of 20.5% during the period of 2019-2024.
53. Communicable Disease Market: A BCC Research Overview
The global market for communicable disease should grow from $57.7 billion in 2019 to $69.4 billion by 2024 at a compound annual growth rate of 3.8% for the period of 2019-2024.
54. Global Stem Cell and Regenerative Therapy Market: A BCC Research Outlook
The global stem cell and regenerative medicines market should grow from $21.8 billion in 2019 to reach $55.0 billion by 2024 at a compound annual growth rate (CAGR) of 20.4% for the period of 2019-202
55. Markets at a Glance: Pharmaceuticals
Examine the trends revolutionizing the pharmaceuticals sector along with an overview of active pharmaceutical ingredients (API), antipsychotic drugs, and neuroprotective agents.
56. Markets at a Glance: Pharmaceuticals
Examine the trends revolutionizing the pharmaceuticals sector along with an overview of active pharmaceutical ingredients (API), antipsychotic drugs, and neuroprotective agents.
57. Antihypertensives: Global Markets to 2023
The global market for antihypertensive drugs should grow from nearly $26.3 billion in 2018 to $27.8 billion by 2023 with a compound annual growth rate (CAGR) of 1.1% for the period of 2018-2023.
